These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 15935566)

  • 1. Hyper-susceptibility of a fusidic acid-resistant mutant of Salmonella to different classes of antibiotics.
    Macvanin M; Hughes D
    FEMS Microbiol Lett; 2005 Jun; 247(2):215-20. PubMed ID: 15935566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fusidic acid-resistant mutants of Salmonella enterica serovar typhimurium have low levels of heme and a reduced rate of respiration and are sensitive to oxidative stress.
    Macvanin M; Ballagi A; Hughes D
    Antimicrob Agents Chemother; 2004 Oct; 48(10):3877-83. PubMed ID: 15388448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The dynamic structure of EF-G studied by fusidic acid resistance and internal revertants.
    Johanson U; Aevarsson A; Liljas A; Hughes D
    J Mol Biol; 1996 May; 258(3):420-32. PubMed ID: 8642600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of transcriptional activators RamA and SoxS on expression of multidrug efflux pumps AcrAB and AcrEF in fluoroquinolone-resistant Salmonella Typhimurium.
    Zheng J; Cui S; Meng J
    J Antimicrob Chemother; 2009 Jan; 63(1):95-102. PubMed ID: 18984645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fusidic acid-resistant EF-G perturbs the accumulation of ppGpp.
    Macvanin M; Johanson U; Ehrenberg M; Hughes D
    Mol Microbiol; 2000 Jul; 37(1):98-107. PubMed ID: 10931308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluoroquinolone treatment of experimental Salmonella enterica serovar Typhimurium DT104 infections in chickens selects for both gyrA mutations and changes in efflux pump gene expression.
    Randall LP; Eaves DJ; Cooles SW; Ricci V; Buckley A; Woodward MJ; Piddock LJ
    J Antimicrob Chemother; 2005 Aug; 56(2):297-306. PubMed ID: 15956100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of intra- and extragenic compensatory mutations in the suppression of fluoroquinolone resistance in a Salmonella Typhimurium gyrA mutant (D87G).
    Preisler A; Heisig P
    J Antimicrob Chemother; 2009 Feb; 63(2):290-4. PubMed ID: 19033246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of several fluoroquinolones and beta-lactams in terms of their capability to restrict the selection of fluoroquinolone-resistant Salmonella: in vitro models.
    Cebríán L; Rodríguez JC; Escribiano I; Royo SG
    APMIS; 2007 Dec; 115(12):1376-82. PubMed ID: 18184408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polyamine effects on antibiotic susceptibility in bacteria.
    Kwon DH; Lu CD
    Antimicrob Agents Chemother; 2007 Jun; 51(6):2070-7. PubMed ID: 17438056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation of spectinomycin resistance mutations in the 16S rRNA of Salmonella enterica serovar Typhimurium and expression in Escherichia coli and Salmonella.
    O'Connor M; Dahlberg AE
    Curr Microbiol; 2002 Dec; 45(6):429-33. PubMed ID: 12402084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms and physiological effects of protamine resistance in Salmonella enterica serovar Typhimurium LT2.
    Pränting M; Andersson DI
    J Antimicrob Chemother; 2010 May; 65(5):876-87. PubMed ID: 20233778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of exposure to fluoroquinolones and beta-lactams on the in vitro activity of other groups of antibiotics in Salmonella spp.
    Cebrian L; Rodríguez JC; Escribano I; Royo G
    APMIS; 2006; 114(7-8):523-8. PubMed ID: 16907858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutant prevention concentration of ciprofloxacin and enrofloxacin against Escherichia coli, Salmonella Typhimurium and Pseudomonas aeruginosa.
    Pasquali F; Manfreda G
    Vet Microbiol; 2007 Jan; 119(2-4):304-10. PubMed ID: 16987619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of global patterns and the genetics of fusidic acid resistance.
    Farrell DJ; Castanheira M; Chopra I
    Clin Infect Dis; 2011 Jun; 52 Suppl 7():S487-92. PubMed ID: 21546625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of novel gyrA mutations in the suppression of the fluoroquinolone resistance genotype of vaccine strain Salmonella Typhimurium vacT (gyrA D87G).
    Preisler A; Mraheil MA; Heisig P
    J Antimicrob Chemother; 2006 Mar; 57(3):430-6. PubMed ID: 16431864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of isolates of Salmonella enterica serovar typhimurium displaying high-level fluoroquinolone resistance in Japan.
    Izumiya H; Mori K; Kurazono T; Yamaguchi M; Higashide M; Konishi N; Kai A; Morita K; Terajima J; Watanabe H
    J Clin Microbiol; 2005 Oct; 43(10):5074-9. PubMed ID: 16207965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fusidic acid-resistant mutants of Salmonella enterica serovar Typhimurium with low fitness in vivo are defective in RpoS induction.
    Macvanin M; Björkman J; Eriksson S; Rhen M; Andersson DI; Hughes D
    Antimicrob Agents Chemother; 2003 Dec; 47(12):3743-9. PubMed ID: 14638476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular mechanisms of decreased susceptibility to fluoroquinolones in avian Salmonella serovars and their mutants selected during the determination of mutant prevention concentrations.
    Kehrenberg C; de Jong A; Friederichs S; Cloeckaert A; Schwarz S
    J Antimicrob Chemother; 2007 May; 59(5):886-92. PubMed ID: 17369276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Commonly used farm disinfectants can select for mutant Salmonella enterica serovar Typhimurium with decreased susceptibility to biocides and antibiotics without compromising virulence.
    Randall LP; Cooles SW; Coldham NG; Penuela EG; Mott AC; Woodward MJ; Piddock LJ; Webber MA
    J Antimicrob Chemother; 2007 Dec; 60(6):1273-80. PubMed ID: 17897935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The acquisition of full fluoroquinolone resistance in Salmonella Typhi by accumulation of point mutations in the topoisomerase targets.
    Turner AK; Nair S; Wain J
    J Antimicrob Chemother; 2006 Oct; 58(4):733-40. PubMed ID: 16895934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.